In this article, we’ll take an in-depth look at the top 10 insider sales last month. Previously, we covered the top 10 insider purchases last month.
The Bureau of Labor Statistics reported Wednesday that February prices for food and services haven’t gone up as much as many experts were expecting. The consumer price index increased by a seasonally adjusted 0.2% for the month, meaning that the annual inflation rate grew 2.8%, slightly lower than economists projected.
Kay Haigh, global co-head of fixed income and liquidity solutions at Goldman Sachs Asset Management said the report reveals “further signs of progress on underlying inflation, with the pace of price increases moderating after January’s strong release,” writes CBS News.
After the “soft inflation” report, the broader market index gained 0.49%, the NASDAQ Composite rose 1.22%, but the blue-chip companies declined 0.2% yesterday, or 3% this week. Despite the decline, and NASDAQ entering a correction, some analysts see it as a normal course for the stocks after strong gains over the past two years, writes CNBC News.
“We’re not surprised the market’s pulled down. Obviously, U.S. equity markets have been exceptionally strong over the last two years,” said Dave Grecsek, managing director of investment strategy and research at Aspiriant Wealth Management. “It’s right to expect a correction. But I think once we get through this — we’re in the very early events of these key fiscal policy changes — there’s better news to come.”
As the market responds to evolving tariff shifts and other political and economic developments, it might be useful to review recent insider trading activity. Why? Company executives have valuable insights into their organizations, and their moves can sometimes help investors obtain more useful data. For instance, when a CEO or CFO buys company stock, it can indicate a positive outlook on the business’s future.
However, it is important to highlight that insider selling isn’t necessarily a sign of a lack of confidence, as it may stem from personal financial considerations or efforts to diversify portfolios. Executives frequently execute these transactions through pre-established plans (such as 10b5-1 plans), which are designed to avoid any appearance of improper timing.
While insider activity can offer useful data, it’s important to consider it in the broader context of other factors, such as the company’s financial performance, market trends, and industry developments.
An executive in a suit and glasses discussing the latest market conditions at a trading desk.
Our Methodology
Using Insider Monkey’s insider trading screener, we’ve identified stocks where at least three insiders sold shares in the past month. From this group, we’ve highlighted the 10 stocks with the highest insider sales values.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
For each stock, we provide details on the total value of insider sales and the company’s current market capitalization. Let’s take a look at the top 10 insider sales from last month.
10. Karman Holdings Inc. (NYSE:KRMN)
Total value of insider sales in February: $226,306,916.00
Market capitalization: $3.98 billion
We start this list with a U.S.-based manufacturer of space and defense systems, located in Huntington Beach, California. Valued at around $4 billion, the company recently completed its initial public offering.
In February, five insiders sold a total of $226.31 million worth of Karman shares at $22.00 per share. Since its IPO in mid-February, the stock rose by 0.57%.
Based on the analysis of five analysts, Karman stock has an average rating of “Strong Buy.” The 12-month price target is $38.75, indicating a potential rise of 28.10% from its current price, writes StockAnalysis.
9. Walmart Inc. (NYSE:WMT)
Total value of insider sales in February: $245,621,439.03
Market capitalization: $684.45 billion
Walmart is a global retailer operating across retail, wholesale, and eCommerce sectors. The company is divided into three main segments: Walmart U.S., Walmart International, and Sam’s Club. It operates a variety of store formats, including supercenters, supermarkets, hypermarkets, warehouse clubs, cash-and-carry stores, and discount stores under the Walmart and Walmart Neighborhood Market brands.
Recently the company announced an annual cash dividend for fiscal year 2026 of $0.94 per share, which represents a 13% increase from the $0.83 per share paid for the last fiscal year.
In February, seven insiders sold a total of $245.62 million worth of Walmart shares at an average price of $97.94 per share. Year-to-date, the stock has declined 6.67% and now trades at $84.32 per share. However, over the past 12 months, Walmart returned 37.46% to its investors.
Based on the views of 32 analysts, Walmart stock holds an average rating of “Strong Buy.” The 12-month price target is $101.53, reflecting a potential increase of 20.30% from its current price, writes StockAnalysis.
8. JPMorgan Chase & Co. (NYSE:JPM)
Total value of insider sales in February: $250,478,121.36
Market capitalization: $637.23 billion
A well-known name in the finance world, JPMorgan Chase & Co. has millions of customers across 100 global markets. Based in New York, the company is concentrated on investment banking and financial services for all types of customers in the commercial and business sectors. As of December 31, JP Morgan Chase & Co. had $4.0 trillion in assets and $345 billion in stockholders’ equity.
In a recent development, the company announced it would buy back all 300,000 of its outstanding shares of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series HH. These shares are represented by 3,000,000 depositary shares, with each depositary share representing one-tenth of a share of Series HH Preferred Stock. The company will pay $10,000 for each Series HH Preferred Stock share, which is equivalent to $1,000 for each depositary share.
In February, nine insiders sold a total of $250.48 million worth of shares, at an average price of $272.13 per share. Currently, the stock trades at $225.67 per share, having declined 5.86% since the beginning of the year. Over the past 12 months, JPMorgan Chase & Co. returned 17.92% to its investors.
Nineteen analysts have given a “Moderate Buy” rating on JPMorgan Chase & Co. stock with a price target of $252.89, according to MarketBeat.
7. Tempus AI, Inc. (NASDAQ:TEM)
Total value of insider sales in February: $256,330,551.71
Market capitalization: $7.84 billion
Seventh among the top 10 insider sales last month is a technology-driven healthcare company Tempus AI. Based in Chicago, Illinois, Tempus AI is focused on leveraging artificial intelligence and machine learning to enhance precision medicine. The company holds one of the largest global databases of clinical and molecular information, supported by a platform designed to make this data both readily available and actionable.
Recently, Tempus AI finalized the acquisition of a big player in genetic testing, Ambry Genetics, in a deal valued at $375 million in cash and $225 million in stock.
In February, eight insiders sold a total of $256.33 million worth of Tempus AI shares at an average price of $78.29 per share. Since the beginning of the year, the stock rose 28.02% and is now trading at $43.22 per share. Since the company’s IPO in June 2024, the stock returned 7.44% to its investors.
For the full 2024, Tempus AI disclosed revenue of $693 million, up by 30% year-over-year. In the fourth quarter, its revenue grew 35.7% to $200.7 million. The company attributed this strong revenue growth to market adoption of both genomic testing and data services.
Based on 11 analysts’ estimates, Tempus AI is a “Buy” with a 12-month price target of $61.22, according to StockAnalysis.
6. Cencora, Inc. (NYSE:COR)
Total value of insider sales in February: $319,403,491.08
Market capitalization: $49.203 billion
Previously known under the name AmerisourceBergen Corporation, Cencora distributes pharmaceuticals in the U.S. and internationally. Based in Conshohocken, Pennsylvania, Cencora provides pharmaceuticals, over-the-counter products, home healthcare supplies, and related services to hospitals, pharmacies, clinics, and long-term care providers. Its offering includes packaging, clinical trial support, animal health products, vaccines, blood products, etc.
In February, three insiders sold a total of $319.40 million at an average price of $246.68 per share. Year-to-date, the stock rose 13.47% and is now trading at $254.94 per share. Over the past 12 months, Cencora returned 8.59% to its investors.
In the first quarter of fiscal 2025, the company had revenue of $81.5 billion, up by 12.8% from the same period of fiscal 2024. GAAP diluted earnings per share was $2.50, which compares to $2.98 in the comparable quarter of the prior year.
Ten analysts have given an average “Moderate Buy” rating on Cencora stock with a price target of $277.90, according to MarketBeat.
5. Meta Platforms, Inc. (NASDAQ:META)
Total value of insider sales in February: $364,360,111.29
Market capitalization: $1.57 trillion
In the middle of the top 10 insider sales last month is a globally popular technology company that manages social media platforms, digital advertising services, and virtual and augmented reality technologies, Meta. The company is making significant investments in the development of artificial intelligence infrastructure, with plans to allocate between $60 billion and $65 billion toward AI initiatives in 2025. It is one of the 10 best growth stocks to invest in for the next 10 years.
In February, six insiders sold a total of $364.36 million worth of Meta shares at a price of $703.91 per share.
For the fourth quarter of 2024, Meta reported revenue of $48.39 billion, compared to revenue of $40.11 billion in the same period of 2023. Net income amounted to $20.84 billion, which compares to $14.02 billion in the corresponding quarter of the prior year.
As per 48 analysts’ estimates, Meta is a “Strong Buy” with a price target of $764.61 per share, according to TipRanks.
4. Rumble Inc. (NASDAQ:RUM)
Total value of insider sales in February: $522,661,515.00
Market capitalization: $2.61 billion
Rumble is a global video-sharing platform with a presence in the U.S. and Canada. Headquartered in Longboat Key, Florida, the company offers a free video-sharing and live streaming service through rumble.com, where users can subscribe to channels, view on-demand videos, and watch live broadcasts. Additionally, Rumble provides a local.com platform, enabling users to purchase subscriptions to support creators and gain access to exclusive content. It is also one of the 10 stocks with at least $20 million in insider sales recently.
In a recent development, Rumble revealed that President Donald Trump has launched an official White House channel on the platform.
In February, seven insiders sold a total $522.66 million at a price of $7.50 per share. Currently, the stock trades at $7.86 per share, having dropped 39.59% year-to-date. Over the past 12 months, Rumble shares declined 7.31%.
The company disclosed fourth-quarter revenue of $25.1 million, up by 39% from the fourth quarter of 2023. Net loss was $31.5 million, compared to a net loss of $29 million in the same period of 2023. As of September 30, 2024, Rumble’s balance of cash, cash equivalents and marketable securities was approximately $132 million.
According to StockAnalysis, three analysts have given an average “Buy” rating on the stock with a price target of $16.50.
3. Zurn Elkay Water Solutions Corporation (NYSE:ZWS)
Total value of insider sales in February: $899,766,451.36
Market capitalization: $5.53 billion
Zurn Elkay, a leader in sustainable water solutions, is headquartered in Milwaukee, Wisconsin. The company designs, manufactures, and distributes water management products across the U.S., Canada, and internationally. Zurn Elkay’s product portfolio includes water dispensers, filtration systems, faucets, backflow preventers, valves, and various other solutions under the Elkay, Halsey Taylor, Zurn, and Wilkins brands. Additionally, the company offers flow systems, oil and grease interceptors, sensor-operated flush valves, heavy-duty commercial faucets, water-saving fixtures, sinks, and restroom products.
For the full year 2025, Zurn Elkay reported net sales of $1.57 billion, reflecting a 2% increase from $1.53 billion in 2023. Net income from continuing operations reached $159 million, or $0.91 per diluted share, compared to $104 million, or $0.59 per diluted share, in the previous year. Adjusted EBITDA was $390 million, up from $340 million in 2023. In 2024, the company repurchased $150 million in common stock and distributed $57 million in common stock dividends.
In February, five insiders sold a total of $899.77 million worth of Zurn Elkay shares at an average price of $35.35 per share. The stock is currently trading at $32.69, having declined 12.36% since the beginning of the year. Over the past 12 months, its shares rose 3.25%.
Five analysts have given an average “Hold” rating on Zurn Elkay stock and a price target of $40.0, suggesting a 22.36% upside, according to TipRanks.
2. DoorDash, Inc. (NASDAQ:DASH)
Total value of insider sales in February: $955,277,285.43
Market capitalization: $78.85 billion
DoorDash is a global technology company that connects consumers with local businesses across more than 25 countries. Established in 2013, DoorDash creates innovative products and services that help businesses grow, reach new customers, and stay competitive. It is also one of the 10 best delivery stocks to buy according to billionaires.
In February, nine insiders sold a total of $955.28 million worth of DoorDash shares at an average price of $198.86 per share. Year-to-date, the stock rose 8.49% and is now trading at $182.00. Furthermore, over the past 12 months, its shares gained 37.44%.
For the fourth quarter of 2024, the company disclosed revenue of $2.9 billion, up by 25% from the same period of 2023. Total orders increased 19% year-over-year to 685 million, and GAAP net income was $141 million, which compares to GAAP net loss of $154 million in the fourth quarter of 2023.
Thirty-four analysts have given an average “Moderate Buy” rating on DoorDash stock with a price target of $206.52, according to MarketBeat.
1. Waystar Holding Corp. (NASDAQ:WAY)
Total value of insider sales in February: $1,138,134,041.84
Market capitalization: $6.35 billion
The first stock among those with top 10 insider sales last month is a company that creates cloud-based software solutions designed for healthcare payment processing, Waystar Holding. The platform provides various services such as revenue capture, patient financial care, denial prevention and recovery, reporting and analytics, financial clearance, and claims and payment management. Based in Lehi, Utah, the company serves roughly 30,000 clients, covering over 1 million providers and 16 out of 20 institutions on the U.S. News Best Hospitals Honor Roll. Waystar’s platform processes more than 6 billion healthcare payment transactions annually, managing over $1.8 trillion in gross claims and serving about 50% of patients.
In February, six insiders sold a total of $1.14 billion worth of Waystar shares at an average price of $40.39 per share. Currently, the stock is trading at $35.65, having lost 2.86% since the beginning of the year. However, since the company’s IPO in June last year, Waystar stock returned 72.22% to its investors.
For the fourth quarter of 2024, Waystar posted revenue of $244.1 million, marking an 18% increase year-over-year. Net income reached $19.1 million, a significant turnaround from a net loss of $14.42 million in the same quarter of 2023. Adjusted EBITDA was $100.2 million, up from $86.2 million in the corresponding quarter of the previous year.
Looking ahead to 2025, the company projects total revenue between $1.0 billion and $1.016 billion, with adjusted EBITDA expected to range from $399 million to $407 million.
Based on seven Wall Street analysts’ estimates, Waystar is a “Strong Buy” with a price target of $49.86, writes TipRanks.
Overall, WAY ranks first among the top 10 insider sales last month. While we acknowledge the potential of WAY, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than WAY but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
